Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Caribou Biosciences Inc (NASDAQ: CRBU) closed at $1.52 in the last session, down -0.65% from day before closing price of $1.53. In other words, the price has decreased by -$0.65 from its previous closing price. On the day, 1.37 million shares were traded. CRBU stock price reached its highest trading level at $1.58 during the session, while it also had its lowest trading level at $1.51.
Ratios:
We take a closer look at CRBU’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.38 and its Current Ratio is at 7.38. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on June 03, 2024, Downgraded its rating to In-line and sets its target price to $3 from $13 previously.
On October 31, 2023, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $13.Evercore ISI initiated its Outperform rating on October 31, 2023, with a $13 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRBU now has a Market Capitalization of 138545568 and an Enterprise Value of -63896916. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.00 while its Price-to-Book (P/B) ratio in mrq is 0.49. Its current Enterprise Value per Revenue stands at -5.568 whereas that against EBITDA is 0.405.
Stock Price History:
The Beta on a monthly basis for CRBU is 2.33, which has changed by -0.706334 over the last 52 weeks, in comparison to a change of 0.23171377 over the same period for the S&P500. Over the past 52 weeks, CRBU has reached a high of $8.33, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is -22.27%, while the 200-Day Moving Average is calculated to be -34.80%.
Shares Statistics:
According to the various share statistics, CRBU traded on average about 1.57M shares per day over the past 3-months and 1640330 shares per day over the past 10 days. A total of 90.55M shares are outstanding, with a floating share count of 79.18M. Insiders hold about 12.56% of the company’s shares, while institutions hold 58.64% stake in the company. Shares short for CRBU as of 1735603200 were 9535766 with a Short Ratio of 6.07, compared to 1732838400 on 8616165. Therefore, it implies a Short% of Shares Outstanding of 9535766 and a Short% of Float of 11.04.
Earnings Estimates
The current assessment of Caribou Biosciences Inc (CRBU) involves the perspectives of 4.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.44 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$1.66 and -$1.75 for the fiscal current year, implying an average EPS of -$1.7. EPS for the following year is -$2.07, with 4.0 analysts recommending between -$1.64 and -$2.91.
Revenue Estimates
For the next quarter, 8 analysts are estimating revenue of $2.75M. There is a high estimate of $3.5M for the next quarter, whereas the lowest estimate is $2M.
